Systematic review / meta-analysis / 2018
Evidence is insufficient to determine if ketogenic diets benefit glioma patients.
Researchers identified six case series and reports comprising 39 participants with glioma, with no randomized clinical trials found. All included reports documented overall survival or progression-free survival, but each carried a high risk of bias. Because of the low-quality evidence, the clinical effectiveness of ketogenic dietary therapies for gliomas could not be determined.
- Study type
- Systematic review
- Who was studied
- 39 patients across 6 case series or reports
- What was measured
- Overall and progression-free survival
THE PAPER
The role of ketogenic diets in the therapeutic management of adult and paediatric gliomas: a systematic review.
Martin-McGill KJ, Srikandarajah N, Marson AG, Tudur Smith C, Jenkinson MD. CNS Oncol, 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.